Updates are available Correction dated 2025-02-06

Article History

Received: 18 September 2024

Accepted: 18 November 2024

First Online: 17 December 2024

Change Date: 6 February 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s13300-025-01698-8

Declarations

:

: Laurence Kessler reports consulting fees from Medtronic, Vertex, Abbott, Novo Nordisk; honoraria or payment for lectures, presentations, and educational events from Johnson and Johnson, Lilly Boehringer, Brothier, GSK, AstraZeneca, Sanofi-Aventis, Novartis, BMS, Elivie, Vertex, ASDIA, ISIS Santé, ADIRAL. Charles Thivolet reports personal fees from Abbott Diabetes Care, Glooko, Lilly, Novo Nordisk, Medtronic, and Sanofi and is an advisory board member for Insulet and Medtronic. Alfred Penfornis reports consulting fees from Medtronic, Insulet, Abbott Diabetes, Novo Nordisk, Medtrum, and Sanofi; honoraria or payment for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Novo Nordisk, Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes, Abbott, AstraZeneca, Dexcom, and Diabeloop; payment for expert testimony and support for travel and attending meetings from Sanofi Diabetes and Isis. Didier Gouet reports honoraria or payment for lectures, presentations in symposium and for participation on advisory board from Lilly, Novo Nordisk, Sanofi, Abbott, Medtronic, Roche, AstraZeneca, LVL, Vitalaire, Isis, NHC, and Dexcom. Christine Coffin reports honoraria or payment for presentations, speaker bureaus and educational events from Novo Nordisk, Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes and Abbot Diabetes; support for travel and attending meetings from Novo Nordisk and Sanofi. Myriam Moret reports payment for support for travel and attending meetings from Lilly Diabetes, ISIS Diabetes, LVL Médical; was an investigator on studies from URGO Laboratories and from TIMKL. Sophie Borot reports honoraria or payment for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Novo Nordisk, Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes, and Dexcom. Saïd Bekka reports consulting fees from Novo Nordisk, Lilly Diabetes, Sanofi, Medtronic, Dexcom, AstraZeneca; participation on advisory boards for Medtronic, Lilly, and Novo Nordisk. Emmanuel Sonnet reports consulting fees from Medtronic, Abbott Diabetes, Glooko and Lilly Diabetes; honoraria or payment for lectures, presentations, speaker bureaus, manuscript writing, and educational events from Novo Nordisk, Medtronic, Dexcom, Tandem, Ypsomed, Sanofi Diabetes, and Glooko. Michael Joubert reports consultant and/or speaker fees and/or research support from Abbott, Air Liquide Santé International, Amgen, Asdia, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Dexcom, Dinno Santé, Glooko, Insulet, Lifescan, Lilly, LVL Médical, Medtronic, MSD, Nestlé HomeCare, Novo Nordisk, Organon, Orkyn, Roche Diabetes, Sanofi, Tandem, Vitalaire, Voluntis, and Ypsomed as well as being an Editorial Board member of Diabetes Therapy (Michael Joubert was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions). Sandrine Lablanche reports consulting fees from Medtronic, Dexcom, Ypsomed and Sanofi; honoraria or payment for lectures, presentations, and educational events from Medtronic, Insulet, Lilly Diabetes, Sanofi Diabetes, Vitalaire, Abbott, and Boehringer. Geoffrey Burtin is a current employee of Medtronic. Fabio Di Piazza is a current employee of Medtronic. Tim van den Heuvel is a current employee of Medtronic. Ohad Cohen is a current employee of Medtronic.

: All participants or, for minors, their guardians provided informed consent. The study was approved by the French Central Ethics Committee (Comité de Protection des Personnes Sud-Est II; 2019-A01668-49; January 8, 2020) and conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.